|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 288.90 GBX | -1.06% |
|
+1.37% | -17.93% |
| 11-24 | EARNINGS AND TRADING: IntelliAM AI fundraise; Synectics extends deal | AN |
| 11-03 | Northcoders contract wins; Verici Dx completes audit | AN |
| Fiscal Period: November | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -5.36 | -0.95 | 1.29 | 3.47 | 4.85 | |||||
Return on Total Capital | -8.12 | -1.38 | 1.77 | 4.74 | 7.13 | |||||
Return On Equity % | -11.98 | -1.32 | 1.77 | 5.7 | 7.93 | |||||
Return on Common Equity | -11.98 | -1.32 | 1.77 | 5.7 | 7.93 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 32.69 | 35.79 | 42.51 | 40.72 | 42.9 | |||||
SG&A Margin | 44.45 | 37.77 | 39.7 | 34.5 | 34.32 | |||||
EBITDA Margin % | -10.51 | -1.43 | 3.96 | 6.84 | 9.09 | |||||
EBITA Margin % | -11.71 | -1.97 | 2.82 | 6.22 | 8.59 | |||||
EBIT Margin % | -11.76 | -1.98 | 2.82 | 6.22 | 8.59 | |||||
Income From Continuing Operations Margin % | -10.46 | -1.1 | 1.63 | 4.4 | 5.7 | |||||
Net Income Margin % | -10.46 | -1.1 | 3.75 | 4.4 | 5.7 | |||||
Net Avail. For Common Margin % | -10.46 | -1.1 | 1.63 | 4.4 | 5.7 | |||||
Normalized Net Income Margin | -7.56 | -1.41 | 1.55 | 3.76 | 5.27 | |||||
Levered Free Cash Flow Margin | 13.54 | -3.68 | -2.28 | 1.4 | 9.91 | |||||
Unlevered Free Cash Flow Margin | 13.76 | -3.51 | -2.07 | 1.53 | 10.03 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.73 | 0.77 | 0.73 | 0.89 | 0.9 | |||||
Fixed Assets Turnover | 10.96 | 8.53 | 8.17 | 11.79 | 14.8 | |||||
Receivables Turnover (Average Receivables) | 2.23 | 2.8 | 2.7 | 3.01 | 3.08 | |||||
Inventory Turnover (Average Inventory) | 5.12 | 6.51 | 5.51 | 6.27 | 4.45 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.48 | 1.63 | 2.12 | 1.96 | 1.77 | |||||
Quick Ratio | 1.21 | 1.35 | 1.69 | 1.58 | 1.29 | |||||
Operating Cash Flow to Current Liabilities | 0.29 | -0.04 | 0.11 | 0.19 | 0.39 | |||||
Days Sales Outstanding (Average Receivables) | 163.98 | 130.38 | 135.3 | 121.44 | 118.94 | |||||
Days Outstanding Inventory (Average Inventory) | 71.47 | 56.05 | 66.19 | 58.21 | 82.2 | |||||
Average Days Payable Outstanding | 75.66 | 54.39 | 60.1 | 53.88 | 58.2 | |||||
Cash Conversion Cycle (Average Days) | 159.79 | 132.04 | 141.39 | 125.77 | 142.94 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 7.53 | 8.03 | 7.62 | 4.98 | 4.57 | |||||
Total Debt / Total Capital | 7.01 | 7.44 | 7.08 | 4.75 | 4.37 | |||||
LT Debt/Equity | 5.18 | 5.72 | 5.78 | 3.51 | 2.88 | |||||
Long-Term Debt / Total Capital | 4.82 | 5.3 | 5.37 | 3.34 | 2.75 | |||||
Total Liabilities / Total Assets | 38.09 | 34.71 | 29.42 | 32.53 | 37.23 | |||||
EBIT / Interest Expense | -34.54 | -7.12 | 8.29 | 30.26 | 42.79 | |||||
EBITDA / Interest Expense | -23.73 | 2.54 | 17.09 | 40.79 | 51.44 | |||||
(EBITDA - Capex) / Interest Expense | -25.89 | 1.93 | 16.44 | 38.09 | 47.8 | |||||
Total Debt / EBITDA | -0.77 | 9.25 | 1.24 | 0.47 | 0.33 | |||||
Net Debt / EBITDA | 1.13 | -5.87 | -0.63 | -0.65 | -1.33 | |||||
Total Debt / (EBITDA - Capex) | -0.71 | 12.13 | 1.29 | 0.5 | 0.35 | |||||
Net Debt / (EBITDA - Capex) | 1.04 | -7.7 | -0.66 | -0.69 | -1.43 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | -34.83 | -2.36 | 6.77 | 25.6 | 13.6 | |||||
Gross Profit, 1 Yr. Growth % | -37.35 | 6.91 | 17.62 | 20.31 | 19.67 | |||||
EBITDA, 1 Yr. Growth % | -250.55 | -86.81 | -386.67 | 117.68 | 50.91 | |||||
EBITA, 1 Yr. Growth % | -300.27 | -83.64 | -231.86 | 164.59 | 56.81 | |||||
EBIT, 1 Yr. Growth % | -302.94 | -83.65 | -231.03 | 165.28 | 56.81 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -386.56 | -89.75 | -244.57 | 238.5 | 46.97 | |||||
Net Income, 1 Yr. Growth % | -386.56 | -89.75 | -405.85 | 47.64 | 46.97 | |||||
Normalized Net Income, 1 Yr. Growth % | -317.47 | -81.88 | -202.54 | 189.99 | 59.22 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -388.54 | -89.76 | -244.57 | 238.29 | 42.97 | |||||
Accounts Receivable, 1 Yr. Growth % | -34.43 | -3.43 | -10.48 | 38.66 | -9.02 | |||||
Inventory, 1 Yr. Growth % | -34.13 | -15.55 | 7.19 | 20.15 | 82.36 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 80.54 | -5 | -7.69 | -18.68 | 1.66 | |||||
Total Assets, 1 Yr. Growth % | -4.63 | -9.49 | -3.17 | 9.92 | 14.26 | |||||
Tangible Book Value, 1 Yr. Growth % | -19.13 | -8.85 | 12.16 | 10.44 | 7.52 | |||||
Common Equity, 1 Yr. Growth % | -9.59 | -4.56 | 4.69 | 5.07 | 6.31 | |||||
Cash From Operations, 1 Yr. Growth % | -387.55 | -110.55 | -302.47 | 146.87 | 180.69 | |||||
Capital Expenditures, 1 Yr. Growth % | -53.4 | -77.81 | 17.81 | 217.44 | 49.08 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -353.06 | -126.61 | -43.64 | -179.86 | 704.95 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -364.15 | -124.97 | -46.71 | -196.52 | 646.53 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | 33.33 | 50 | 50 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | -20.84 | -20.23 | -6.4 | 15.8 | 19.45 | |||||
Gross Profit, 2 Yr. CAGR % | -21.9 | -18.16 | 6.75 | 18.95 | 19.99 | |||||
EBITDA, 2 Yr. CAGR % | 15.92 | -55.32 | -42.7 | 149.48 | 81.24 | |||||
EBITA, 2 Yr. CAGR % | 32.31 | -42.63 | -54.12 | 90.97 | 103.69 | |||||
EBIT, 2 Yr. CAGR % | 33.11 | -42.28 | -54.28 | 90.62 | 103.95 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 74.44 | -45.79 | -63.01 | 121.22 | 123.05 | |||||
Net Income, 2 Yr. CAGR % | 74.44 | -45.79 | -44 | 112.5 | 47.31 | |||||
Normalized Net Income, 2 Yr. CAGR % | 37.53 | -37.09 | -57.74 | 76.83 | 114.88 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 74.47 | -45.64 | -63.04 | 121.15 | 119.92 | |||||
Accounts Receivable, 2 Yr. CAGR % | -8.53 | -20.43 | -7.02 | 11.42 | 12.32 | |||||
Inventory, 2 Yr. CAGR % | -21.85 | -25.42 | -4.86 | 13.48 | 48.02 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 38.63 | 30.97 | -6.35 | -13.36 | -9.08 | |||||
Total Assets, 2 Yr. CAGR % | -1.21 | -7.09 | -6.38 | 3.17 | 12.07 | |||||
Tangible Book Value, 2 Yr. CAGR % | -9.05 | -14.15 | 1.11 | 11.29 | 5.25 | |||||
Common Equity, 2 Yr. CAGR % | -4.64 | -7.11 | -0.04 | 4.88 | 5.69 | |||||
Cash From Operations, 2 Yr. CAGR % | -0.67 | -44.91 | -53.77 | 123.57 | 163.23 | |||||
Capital Expenditures, 2 Yr. CAGR % | -12.12 | -67.84 | -48.87 | 93.38 | 117.54 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 13.23 | -18.03 | -61.56 | -34.1 | 153.54 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 13.32 | -18.89 | -63.68 | -29.68 | 168.44 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | 7.42 | - | 41.42 | 50 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | -13.96 | -15.1 | -17.04 | 3.24 | 15.06 | |||||
Gross Profit, 3 Yr. CAGR % | -15.22 | -13.28 | -10.63 | 11.09 | 19.19 | |||||
EBITDA, 3 Yr. CAGR % | 7.7 | -43.73 | -20.8 | -10.66 | 110.99 | |||||
EBITA, 3 Yr. CAGR % | 17.88 | -33.99 | -24.91 | -16.5 | 78.82 | |||||
EBIT, 3 Yr. CAGR % | 18.34 | -33.74 | -24.76 | -16.63 | 78.61 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 30.49 | -32.17 | -26.81 | -22.63 | 93.03 | |||||
Net Income, 3 Yr. CAGR % | 30.49 | -32.17 | -3.5 | -22.63 | 87.93 | |||||
Normalized Net Income, 3 Yr. CAGR % | 21.4 | -29.92 | -26.93 | -18.33 | 70.76 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 30.72 | -32.2 | -26.68 | -22.69 | 91.22 | |||||
Accounts Receivable, 3 Yr. CAGR % | -11.6 | -6.86 | -17.24 | 6.23 | 4.14 | |||||
Inventory, 3 Yr. CAGR % | -21.01 | -19.81 | -15.83 | 2.84 | 32.92 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 23.31 | 22.22 | 16.55 | -10.66 | -8.62 | |||||
Total Assets, 3 Yr. CAGR % | -2.06 | -4.05 | -5.8 | -1.24 | 6.74 | |||||
Tangible Book Value, 3 Yr. CAGR % | -4.19 | -8.99 | -6.15 | 4.13 | 7.5 | |||||
Common Equity, 3 Yr. CAGR % | -2.19 | -4.61 | -3.33 | 1.63 | 5.35 | |||||
Cash From Operations, 3 Yr. CAGR % | 16.07 | -52.95 | -14.98 | -19.2 | 141.18 | |||||
Capital Expenditures, 3 Yr. CAGR % | 2.11 | -44.46 | -50.43 | -6.03 | 77.32 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 20.79 | -30.18 | -28.01 | -51.53 | 51.77 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 20.34 | -31.61 | -29.69 | -50.35 | 54.55 | |||||
Dividend Per Share, 3 Yr. CAGR % | - | -31.66 | 15.44 | - | 44.22 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | -8.21 | -9.27 | -11.01 | -7.17 | -4.02 | |||||
Gross Profit, 5 Yr. CAGR % | -7.32 | -8.18 | -7.03 | -3.52 | 0.55 | |||||
EBITDA, 5 Yr. CAGR % | 14.89 | -29 | -16.24 | -0.76 | 10.23 | |||||
EBITA, 5 Yr. CAGR % | 25 | -21.33 | -19.11 | 0.46 | 12.92 | |||||
EBIT, 5 Yr. CAGR % | 26.73 | -20.82 | -19.04 | 0.62 | 13.12 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 63 | -20.1 | -21.19 | 7.1 | 14.29 | |||||
Net Income, 5 Yr. CAGR % | 63 | -20.1 | -6.97 | 7.1 | 14.29 | |||||
Normalized Net Income, 5 Yr. CAGR % | 30.54 | -17.81 | -20.33 | 0.68 | 13.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 62.03 | -20.26 | -21.13 | 7.06 | 13.77 | |||||
Accounts Receivable, 5 Yr. CAGR % | -3.95 | -7.68 | -9.8 | 0.06 | -6.49 | |||||
Inventory, 5 Yr. CAGR % | -14.81 | -17.01 | -14.91 | -7.86 | 5.49 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 9.94 | 10.12 | 10.46 | 6.51 | 5.53 | |||||
Total Assets, 5 Yr. CAGR % | -0.66 | -4.12 | -3.81 | -1.22 | 0.98 | |||||
Tangible Book Value, 5 Yr. CAGR % | -0.15 | -4.35 | -2.1 | -1.36 | -1.74 | |||||
Common Equity, 5 Yr. CAGR % | 0.1 | -2.24 | -1.33 | -0.92 | 0.18 | |||||
Cash From Operations, 5 Yr. CAGR % | -3.84 | -25.31 | -19.69 | -12.24 | 33.61 | |||||
Capital Expenditures, 5 Yr. CAGR % | -1 | -26.91 | -22.57 | -8.51 | -10.43 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -1.16 | -0.46 | -23.63 | -31.98 | 18.27 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -1.2 | -2.49 | -25.51 | -30.96 | 19.22 | |||||
Dividend Per Share, 5 Yr. CAGR % | - | -5.59 | -12.94 | -8.59 | 28.19 |
- Stock Market
- Equities
- SNX Stock
- Financials Synectics plc
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















